Application of Gene Therapy in Hemophilia.

Hu, Yue-Fen; Fang, Yun-Hai; Lai, Yong-Rong; Feng, Xiao-Qin; Xu, Shu-Qian

Hu, Yue-Fen; Fang, Yun-Hai; Lai, Yong-Rong; Feng, Xiao-Qin; Xu, Shu-Qian.

Afiliación

Hu YF; Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250014, China.
Fang YH; Shandong Blood Center, Shandong Hemophilia Treatment Center, Jinan, 250014, China.
Lai YR; Department of Hematology, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
Feng XQ; Nanfang Hospital, Southern Medical University, Guangzhou, 510000, China.
Xu SQ; Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250014, China. shuqian.xu@email.sdu.edu.cn.

Curr Med Sci ; 42(5): 925-931, 2022 Oct.

Article en En | MEDLINE | ID: mdl-36260269

Asunto(s)

Hemofilia A; Humanos; Hemofilia A/genética; Hemofilia A/terapia; Sistemas CRISPR-Cas; Edición Génica/métodos; Terapia Genética/métodos; Anticuerpos Neutralizantes

Palabras clave

CRISPR-Cas9; application; gene therapy; hemophilia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hemofilia A Límite: Humans Idioma: En Revista: Curr Med Sci Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google